Enterprise Ireland

Galway Biomedical is a medical device company that specializes in the development and manufacturing of surgical implants. Their products cater to various clinical fields, including vascular, dental, orthopaedic, urology, and general surgery, contributing to advancements in biomaterial-based medical devices.

NUA Surgical is an innovative start-up located at the Innovation Hub in Galway, Ireland, focused on enhancing women's health through advanced medical devices. The company has developed a patented surgical retractor specifically designed to improve the safety and efficiency of cesarean deliveries. By concentrating on research and development, NUA Surgical aims to provide obstetricians with tools that facilitate superior surgical outcomes, ultimately making C-sections safer for patients.

Ovagen is a biotechnology company specializing in the large-scale production of germ-free chicken eggs and birds, primarily for the pharmaceutical industry. The company's innovative process utilizes a transgenic chicken platform to produce recombinant proteins to Good Manufacturing Practice (GMP) standards. This technology provides pharmaceutical companies with a biosecure and flexible biomanufacturing solution for developing vaccines and therapeutic proteins. In addition to its core offerings, Ovagen also provides Contract Research Services and has expertise in specific poultry and rodent research technologies, as well as in SPF poultry and rodent housing and husbandry.

SymPhysis Medical focuses on developing innovative medical technologies aimed at treating chronic diseases, with an emphasis on enhancing patient experience and quality of life. The company's flagship product, releaze, addresses malignant pleural effusion (MPE), a common complication in late-stage cancer patients that can lead to severe shortness of breath and chest pain. This therapeutic device is designed for home use, effectively draining excess fluid from the pleural space. By utilizing an active component that enhances fluid removal efficiency, releaze alleviates distressing symptoms and improves treatment accessibility for patients requiring indwelling pleural catheter (IPC) therapies.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Vertigenius operates a digital platform for vestibular rehabilitation, assisting clinicians in managing patients with dizziness and balance issues. The platform enables clinicians to design and prescribe customized exercises, which patients can access and track using a mobile application. Vertigenius also employs a head sensor for patient consultations.

NeuroBell is a medical technology company specializing in the development of a portable EEG monitoring device for newborn infants. This device enables real-time, automated detection and alerting of neonatal seizures, facilitating quicker diagnoses and improved patient outcomes. It offers wireless connectivity, a remote EEG web viewer, and user-friendly features for quick setup and recording by NICU staff, ensuring continuous decision support.

BeyondBMI operates a health technology platform focused on weight management. The company offers personalized support and motivation through a range of services, including access to doctor-prescribed weight loss medications, nutritional therapy, and one-on-one coaching. By providing non-judgmental medical expertise and the latest therapeutic options, BeyondBMI aims to transform the lives of individuals affected by obesity, facilitating their journey towards healthier living.

CergenX specializes in neonatal brain monitoring technology that utilizes artificial intelligence to identify newborns at risk of brain injury. The company develops advanced algorithms and systems for screening brain abnormalities in infants by analyzing brain wave patterns. This innovative approach allows healthcare professionals to detect abnormal activity and potential brain injuries early, enhancing the ability to provide timely intervention for affected newborns. By focusing on scalable solutions, CergenX aims to improve outcomes in neonatal care through early detection and monitoring of brain health.

pHetalSafe is a medical technology company that specializes in the development of an innovative fetal monitoring system. This system measures fetal lactate and pH levels during labor, aiming to more accurately detect fetal distress and hypoxia. By providing health workers with valuable data, pHetalSafe enables them to make informed clinical decisions, ultimately promoting optimal patient outcomes.

NeuroBell is a medical technology company specializing in the development of a portable EEG monitoring device for newborn infants. This device enables real-time, automated detection and alerting of neonatal seizures, facilitating quicker diagnoses and improved patient outcomes. It offers wireless connectivity, a remote EEG web viewer, and user-friendly features for quick setup and recording by NICU staff, ensuring continuous decision support.

Fada Medical specializes in innovative medical technologies aimed at improving chronic drug therapy, particularly for diabetes patients. The company has developed a novel infusion technology that significantly extends the lifespan of cannulas, allowing them to function effectively for up to 30 days. By utilizing soft robotic active diffusion techniques, Fada Medical addresses common issues such as early infusion set failure and cannula occlusion, ensuring consistent insulin delivery. This focus on optimizing infusion systems enhances the quality of treatment for individuals managing diabetes, ultimately making their lives easier.

Novus Diagnostics is focused on developing an innovative diagnostic device that addresses sepsis, a life-threatening condition caused by infections. The company's technology enables rapid detection and classification of pathogens directly from whole blood samples. By providing quick and automated pathogen identification in just minutes, Novus Diagnostics aims to enhance the ability of healthcare providers to treat patients efficiently and effectively, while also maintaining cost-effectiveness in the diagnostic process.

Signum Surgical Limited, founded in 2014 by Eoin Bambury and Moshe Zilversmit, is a medical technology company based in Galway, Ireland. The company focuses on developing innovative solutions for the treatment of perianal fistulas, which are small tunnels that form between the bowel and skin near the anus. Signum Surgical has created a bio-absorbable implant that is used post-surgery to securely close the fistula tract, facilitating a faster healing process and reducing the risk of reinfection. This technology aims to provide an effective long-term treatment option for patients suffering from colorectal conditions.

Impedans specializes in intelligent sensing platforms for radio-frequency (RF) and plasma process monitoring. Their technology is utilized across various sectors, including semiconductor manufacturing, vacuum coating, medical devices, hard disk production, and aerospace, among others. The company's products support applications such as fundamental research, process development, tool design, process control, and fault detection and classification. By offering high-resolution plasma diagnostics and quality performance, Impedans enables clients to obtain accurate process measurements and address complex processing challenges effectively. Their expertise in RF and plasma systems, combined with internet-enabled sensing capabilities, provides an independent diagnosis of process health, helping customers optimize their operations.

CergenX specializes in neonatal brain monitoring technology that utilizes artificial intelligence to identify newborns at risk of brain injury. The company develops advanced algorithms and systems for screening brain abnormalities in infants by analyzing brain wave patterns. This innovative approach allows healthcare professionals to detect abnormal activity and potential brain injuries early, enhancing the ability to provide timely intervention for affected newborns. By focusing on scalable solutions, CergenX aims to improve outcomes in neonatal care through early detection and monitoring of brain health.

seamlessCARE is a digital health start-up focused on improving the quality of life for individuals with communication challenges stemming from various conditions, including autism, stroke, dementia, and intellectual disabilities. The company has developed a care planning platform that enables users to document the daily activities of care recipients, facilitating seamless information transfer to care providers. Additionally, the platform features a translation tool designed to capture the vocalizations of non-verbal individuals, helping them express their emotional states. This innovative approach empowers patients with communication difficulties to convey their feelings independently, enhancing their overall well-being and support.

Gasgon Medical is a medical device company focused on enhancing intravenous (IV) infusion processes to improve patient outcomes and support healthcare professionals. The company develops innovative devices aimed at optimizing clinical efficiency and reducing risks associated with IV administration, such as Vascular Air Embolism. By addressing the challenges faced by clinicians in delivering IV medicine, Gasgon Medical seeks to foster a future where all IV treatments can be administered with confidence, ultimately aiming to elevate the standard of care in healthcare settings.

SymPhysis Medical focuses on developing innovative medical technologies aimed at treating chronic diseases, with an emphasis on enhancing patient experience and quality of life. The company's flagship product, releaze, addresses malignant pleural effusion (MPE), a common complication in late-stage cancer patients that can lead to severe shortness of breath and chest pain. This therapeutic device is designed for home use, effectively draining excess fluid from the pleural space. By utilizing an active component that enhances fluid removal efficiency, releaze alleviates distressing symptoms and improves treatment accessibility for patients requiring indwelling pleural catheter (IPC) therapies.

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

FeelTect is a medical device company based in Galway, Ireland, founded in 2019. The company specializes in developing and marketing a connected-health technology known as Tight Alright, which is designed to measure and monitor sub-bandage pressure during compression therapy for venous leg ulcers (VLUs). This technology addresses a critical challenge in VLU treatment, as improper pressure application can lead to ineffective or dangerous outcomes. By providing live readings and recorded data, FeelTect's device allows both patients and healthcare providers to ensure that compression therapy is applied safely and effectively, ultimately facilitating optimal, individualized treatment regimens. The innovation not only enhances patient care but also aims to reduce the economic burden associated with VLU management.

Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovative solution aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant potential market given that up to 25% of diabetics may develop foot ulcers.

EquiTrace is an application designed to track the identification and health of horses, offering significant benefits to horse owners and registration agencies. The platform enables reliable horse-side technology, facilitating instant access to important information. It is compatible with all microchips, including a bio-thermo microchip that allows for contactless temperature monitoring. By storing medical records and providing rapid identification of disease processes, EquiTrace enhances animal healthcare and supports daily health monitoring for equine patients.

Raydiant Oximetry, Inc. is a medical device company founded in 2015 and headquartered in Mountain View, California. The company focuses on improving childbirth outcomes for mothers and infants by developing a low-cost, non-invasive device that monitors fetal oxygen levels during labor. This innovative technology aims to provide real-time insights into fetal oxygenation, which can help clinicians make informed decisions and reduce the risks associated with childbirth, such as birth injuries and unnecessary cesarean sections. By enhancing patient care and potentially lowering healthcare costs, Raydiant Oximetry's device addresses critical needs in maternal and fetal health.

HealthBeacon Limited is a digital therapeutics company based in Dublin, Ireland, with additional offices in Canada and the United States. Founded in 2013, the company develops a smart sharps system designed to enhance medication adherence for patients using self-injectable medications at home. Its connected device, known as HealthBeacon, monitors patient compliance, identifies behavior patterns, and engages users to improve adherence. The system provides medication reminders, alerts patients when to take their medication, and facilitates safe disposal of sharps. Additionally, it offers educational resources and utilizes artificial intelligence for data analytics to support patients effectively. HealthBeacon operates primarily through a Direct-to-Consumer segment, which generates most of its revenue, alongside a Patient Safety Hub and Patient Support Programs.

InVera Medical is a developer of innovative medical devices aimed at treating varicose veins and venous ulcers. The company focuses on creating less invasive, pain-free treatment options that leverage the body's natural biological responses. Their proprietary technology provides a minimally invasive endovenous treatment that enhances patient safety and efficacy, addressing a significant gap in the market where only a small fraction of the 120 million individuals suffering from venous disease in the US and EU receive adequate care. With an estimated 3 million patients with venous ulcers currently underserved and reliant on ineffective compression bandaging, InVera Medical offers a solution that not only improves treatment outcomes but also seeks to reduce the substantial annual costs incurred by insurers. Their approach is positioned to disrupt conventional treatment practices and expand the indications for superficial venous ablation, ultimately enhancing access to effective care for a broader range of patients.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

AtriAN Medical is an Irish medical device company based in Galway, specializing in innovative treatments for atrial fibrillation. The company has commercialized technology developed at the Mayo Clinic, focusing on a unique approach that utilizes micro Pulsed Electric Fields (mPEF) to selectively ablate hyperactive tissues while preserving surrounding myocardial tissue. AtriAN's device employs a catheter to deliver short pulses of electrical energy to the clusters of neuronal cells responsible for the condition. This method allows for effective treatment without causing damage to the heart muscle, offering physicians a new option in managing atrial fibrillation and improving patient outcomes.

Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovative solution aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant potential market given that up to 25% of diabetics may develop foot ulcers.

THEYA Healthcare is a medical device company that specializes in designing and manufacturing innovative post-surgery garments, particularly for women recovering from breast cancer surgeries. Founded by Ciara Donlon in 2015, the company emerged from a recognized need for comfortable and feminine underwear that catered to the specific requirements of women during their recovery. Theya Healthcare's flagship product line features bras made from a unique bamboo blend fabric, which is proven to be antibacterial, highly absorbent, and effective at wicking moisture away from the skin. Clinical trials conducted in Dublin demonstrated that patients wearing Theya Healthcare bras experienced significant improvements in body image and health status, while also reporting reduced pain and discomfort compared to competing products. Since its inception, Theya Healthcare has garnered numerous accolades for its contributions to women's health, including the Cartier Women's Initiative Award and recognition in the EY Entrepreneur of the Year program.

Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.

CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.

Perfuze is a neurovascular medical device company based in Galway, Ireland, established in 2018. The company specializes in developing innovative catheter technology aimed at treating acute ischemic stroke. By utilizing its proprietary catheter-based aspiration platform, Perfuze focuses on optimizing the efficiency of clot removal, which in turn seeks to enhance clinical outcomes and reduce procedural times. This technology aims to simplify the treatment process while minimizing the need for alternative interventions, providing patients with a cost-effective solution for ischemic stroke therapy.

HealthBeacon Limited is a digital therapeutics company based in Dublin, Ireland, with additional offices in Canada and the United States. Founded in 2013, the company develops a smart sharps system designed to enhance medication adherence for patients using self-injectable medications at home. Its connected device, known as HealthBeacon, monitors patient compliance, identifies behavior patterns, and engages users to improve adherence. The system provides medication reminders, alerts patients when to take their medication, and facilitates safe disposal of sharps. Additionally, it offers educational resources and utilizes artificial intelligence for data analytics to support patients effectively. HealthBeacon operates primarily through a Direct-to-Consumer segment, which generates most of its revenue, alongside a Patient Safety Hub and Patient Support Programs.

Kinesis Health Technologies is a Dublin-based digital health company founded in 2013 that specializes in assessing physical function and falls risk in older adults. The company has developed a patented platform that monitors mobility impairment by categorizing various mobility parameters such as walking, variability, symmetry, transfers, and turning. By comparing individual mobility scores against population data based on age and gender, Kinesis provides a method for objective assessment of gait, mobility, and frailty. With over a decade of research backing its medical device technologies, Kinesis Health Technologies aims to enhance the prevention and assessment of falls risk, contributing significantly to the health and safety of older adults. The company is supported by a team with extensive experience in business, marketing, and technical fields.

Loci Orthopaedics Limited, based in Upper Newcastle, Ireland, specializes in developing innovative medical technologies to address significant unmet clinical needs in orthopedics. Founded in 2017, the company focuses on creating surgical implants, particularly the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, offering a less invasive and easier insertion method compared to existing surgical options. Additionally, Loci Orthopaedics is known for its Osteoanchor surface architecture, which is based on evidence-based designs, enabling clinicians to effectively address challenges in orthopedic extremities.

Neurent Medical Limited is a medical device company based in Galway, Ireland, founded in 2015. The company focuses on developing innovative solutions for treating rhinitis, including both allergic and non-allergic forms. It offers a single-use, minimally invasive device designed for ENT surgeons that utilizes radio-frequency technology to provide non-surgical interventions for chronic rhinitis. The device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization, where it employs a microelectrode array to deliver targeted energy. This approach interrupts the autonomic function within the mucosal structures of the nasal cavities, effectively reversing the inflammatory process. By enabling treatment in an office setting, Neurent Medical aims to eliminate the complications and costs associated with traditional surgical procedures.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.

Incereb is an Irish medical device company based in Dublin, specializing in the neonatal intensive care unit (NICU) market. Founded in May 2011, the company focuses on designing and developing disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products tailored for term and preterm infants. These innovative products require minimal training for medical professionals, significantly simplifying the setup process for monitoring neonates. Incereb's devices are compatible with various EEG and CFM recording equipment, enhancing their versatility in clinical settings. The company is committed to investing in research and development to expand its product offerings and has established strategic partnerships with leading Irish universities and hospitals. These collaborations aim to harness local scientific expertise, facilitating the quick commercialization of new devices and supporting the company’s growth trajectory.

The Hamstring Solo is an exercise aid for carrying out hamstring eccentric and concentric exercises.

Connexicon Medical Ltd. is a Dublin-based company that specializes in the manufacture of tissue adhesives and sealants for medical applications. Established in 2014, the company focuses on developing innovative solutions for wound care, offering products that ensure strong and durable closure of wounds. Their medical adhesives are designed for both topical and internal use, providing enhanced wound closure strength while also delivering microbial barrier protection against common pathogens associated with surgical site infections. This capability enables healthcare professionals to effectively manage wound care and improve patient outcomes.

GlycoSeLect is a biotechnology company focused on developing and producing Recombinant Prokaryotic Lectins (RPLs), which are innovative tools for analyzing and selectively purifying glycosylated biomolecules. Their RPLs have diverse applications in life sciences, including glycobiology, glycoproteomics, biomarker discovery, biomedical diagnostics, and the biopharmaceutical industry, as well as in vaccines and cosmetics. GlycoSeLect's RPLs offer notable advantages over traditional lectin products, including rapid and cost-effective production through recombinant expression in Escherichia coli, high purity, consistent performance, and genetically enhanced binding properties that improve specificity and affinity. The scalable nature of their production also supports large-scale applications, making their technology valuable for various sectors within the life sciences.

Coroflo Ltd. is a company based in Dublin, Ireland, focused on developing a breastfeeding assistance monitoring system and accompanying application software. The primary innovation is a breastfeeding monitor that tracks milk flow from mother to baby, enabling parents to receive real-time data about the amount of breast milk consumed by their infant. Founded in 2017, Coroflo aims to enhance the breastfeeding experience by providing valuable insights that support infant health and nutrition.

Rockfield Medical Devices is a small to medium-sized enterprise focused on transforming the enteral feeding market through innovative design and user-centered solutions. Founded by a team of experts in the medical device industry and research, the company aims to enhance the mobility and quality of life for individuals relying on tube feeding. Rockfield's platform introduces a lightweight and discreet mobile feeding system that significantly improves user experience while reducing technical support and maintenance costs for sales partners. Through its commitment to innovation and usability, Rockfield strives to deliver exemplary satisfaction to end users in the enteral feeding community.

Firmwave Limited specializes in the design, development, and deployment of industrial-grade Internet of Things (IoT) hardware and firmware solutions. Its offerings include the Firmwave Edge platform, which facilitates the efficient and secure management of edge devices for customers in various sectors, including healthcare, smart homes, and smart offices. The company provides a suite of software tools and cloud APIs that enable seamless integration of multiple wireless sensor technologies, allowing for remote management, diagnostics, and over-the-air upgrades through a unified dashboard. Firmwave's design services encompass hardware and RF designs, rapid prototyping, networked embedded systems, and the architecture and deployment of wireless sensor networks. Additionally, the company offers tailored IoT solutions across industries such as construction, energy, logistics, and agriculture. Founded in 2015 and headquartered in Dublin, Ireland, with a location in Gdansk, Poland, Firmwave operates as a subsidiary of Taoglas Limited.

Oculer specializes in the rapid detection of thermoduric bacteria in milk and dairy products through its advanced microbiology laboratory. The company has developed a fully automated platform that offers a low-cost, user-friendly solution for identifying spoilage microorganisms, including bacteria, yeast, and mold. By utilizing patented technologies, Oculer ensures superior sensitivity and specificity compared to traditional microbiological testing methods. This innovation allows food and beverage manufacturers to quickly and accurately detect microbial contamination in their products and processes, ultimately helping them reduce inventory holding costs and minimize the risk of product recalls. Oculer is also working on a suite of products designed for in-process and finished product testing, catering to smaller sample sizes.

CMC Hygea Ltd. is a manufacturer of Class 1 medical devices focused on developing hygienic healthcare products aimed at preventing infectious diseases. The company offers a range of infection control solutions, including a patient bathing system designed to reduce the spread of bacteria that can lead to healthcare-associated infections (HAIs). Additionally, CMC Hygea provides effective methods for cleaning and treating leg ulcers, contributing to improved infection control and prevention within the global healthcare system.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.

Qualio, Inc. specializes in cloud-based quality management software tailored for the life sciences sector, including medical device manufacturers, pharmaceutical and biotech companies, and contract service providers. Founded in 2012 and headquartered in San Francisco, with an office in Dublin, Qualio's platform facilitates compliance with GxP, FDA, and ISO standards, helping organizations streamline premarket activities, registration, and regulatory requirements. The software offers comprehensive features for document control, training, risk management, complaint handling, and internal audits, among others. By uniting teams and processes within a single platform, Qualio enables over 500 companies across 80 countries to enhance efficiency, reduce risks, and foster a culture of quality, ultimately supporting faster market entry and business growth.

PolyDev is a limited company set up to bring specialist innovation to the cosmetic contact lens market. It has a core competence in biomedical inks and printing, and has used this expertise to bring the TORIColors lens to market. PolyDev is the manufacturer of TORIColors brand of cosmetic contact lens. They are on sale in the US currently and will be released to other countries as regulatory compliance is achieved.

OrthoXel DAC is an emerging medical device startup company founded in 2014 to develop and commercialise orthopaedic trauma products. The first technology that OrthoXel will commercialise is a novel intramedullary nail for treatment of tibia and femoral fractures (Apex Nailing system ). The basic R&D and proof of principle was completed in Cork Institute of Technology’s MEDIC centre over a 5 year timeframe. That development program included iterative design-build-test activities such as bench testing, cadaver studies, and a GLP-controlled preclinical study. The output from the development program is patent-protected for tibial, femoral, and humeral use. OrthoXel will bring the Apex Tibial Nailing system through regulatory approval and clinical studies in early 2017, followed by the Apex Femoral Nailing system.

Signum Surgical Limited, founded in 2014 by Eoin Bambury and Moshe Zilversmit, is a medical technology company based in Galway, Ireland. The company focuses on developing innovative solutions for the treatment of perianal fistulas, which are small tunnels that form between the bowel and skin near the anus. Signum Surgical has created a bio-absorbable implant that is used post-surgery to securely close the fistula tract, facilitating a faster healing process and reducing the risk of reinfection. This technology aims to provide an effective long-term treatment option for patients suffering from colorectal conditions.

Kinesis Health Technologies is a Dublin-based digital health company founded in 2013 that specializes in assessing physical function and falls risk in older adults. The company has developed a patented platform that monitors mobility impairment by categorizing various mobility parameters such as walking, variability, symmetry, transfers, and turning. By comparing individual mobility scores against population data based on age and gender, Kinesis provides a method for objective assessment of gait, mobility, and frailty. With over a decade of research backing its medical device technologies, Kinesis Health Technologies aims to enhance the prevention and assessment of falls risk, contributing significantly to the health and safety of older adults. The company is supported by a team with extensive experience in business, marketing, and technical fields.

THEYA Healthcare is a medical device company that specializes in designing and manufacturing innovative post-surgery garments, particularly for women recovering from breast cancer surgeries. Founded by Ciara Donlon in 2015, the company emerged from a recognized need for comfortable and feminine underwear that catered to the specific requirements of women during their recovery. Theya Healthcare's flagship product line features bras made from a unique bamboo blend fabric, which is proven to be antibacterial, highly absorbent, and effective at wicking moisture away from the skin. Clinical trials conducted in Dublin demonstrated that patients wearing Theya Healthcare bras experienced significant improvements in body image and health status, while also reporting reduced pain and discomfort compared to competing products. Since its inception, Theya Healthcare has garnered numerous accolades for its contributions to women's health, including the Cartier Women's Initiative Award and recognition in the EY Entrepreneur of the Year program.

Vivasure Medical Limited is a medical device company based in Galway, Ireland, specializing in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures in the fields of cardiology, interventional radiology, and vascular surgery. Its primary product is a large-bore percutaneous closure device that employs an absorbable patch to effectively close large arteriotomies following transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical is dedicated to advancing medical solutions that enhance patient outcomes in vascular access procedures.

Bluedrop Medical, established in 2014 and headquartered in Galway, Ireland, specializes in the development, manufacturing, and commercialization of an IoT-enabled device for early detection of diabetic foot ulcers. Their home-based system scans patients' feet daily, transmitting data to the cloud for analysis via advanced algorithms, which can identify skin abnormalities. This innovative solution aims to reduce the risk of amputation and improve the lives of diabetic patients, with a significant potential market given that up to 25% of diabetics may develop foot ulcers.

Tapa Healthcare is an Irish Medical Technology start-up supported by Enterprise Ireland, armed with 18 years of clinical research, and the mission of providing proactive patient-centric care.

SiriusXT Limited, based in Dublin, Ireland, specializes in the development and manufacturing of a soft x-ray microscope known as the SXT system. Founded in 2015, the company primarily serves researchers in disease research and drug discovery. The microscope employs a vacuum-based laser-produced plasma light source, enabling high-resolution imaging of the 3D internal structure of cells in their native, fully hydrated state. This technology is akin to a CT scan for cells, allowing for detailed visualization without the need for stains or contrast agents. The SXT system is particularly beneficial for disease researchers, pharmaceutical companies, and biotechnologists, as it facilitates the understanding of disease pathways, protein-drug interactions, and bio-engineering processes. As the first high-throughput, bench-top soft x-ray microscope, SiriusXT's system can produce full cell 3D tomographs in a matter of minutes, significantly advancing imaging capabilities in scientific research.

AventaMed Ltd. is a medical device company based in Cork, Ireland, specializing in the development of a device for the placement of tympanostomy tubes, commonly known as grommets. As a start-up spun out from the MEDIC research centre at the Cork Institute of Technology, AventaMed has built its foundation on four years of product development aimed at enhancing patient care while lowering healthcare costs. The company's innovative device enables the insertion of ear tubes without the need for general anesthetic, facilitating the treatment of recurring ear infections and hearing loss in both children and adults.

DiaNia Technologies, headquartered in Ireland, specializes in materials research and development services aimed at improving the performance and functionality of medical devices. The company focuses on enhancing patient safety and product reliability through innovative features and superior timelines. By leveraging its expertise in materials science and project management, DiaNia Technologies addresses a significant gap in the marketplace, particularly in the early development phase of medical devices. Their services emphasize the intellectual property of extrusion technology, which is particularly beneficial for catheter makers by reducing friction in catheter-based devices. This approach not only enhances device performance but also contributes to cost-effectiveness in the medical device industry.

Contego Sports Limited, founded in 2014 and based in Galway, Ireland, specializes in the manufacture and sale of advanced head guards for rugby players. The company's flagship product, the N-Pro head guard, is designed to reduce the incidence and severity of brain injuries by effectively managing head impact energy. The founders, Mark and Dr. Sandra Ganly, leverage their extensive expertise in sports equipment design and biomedical engineering to create innovative protective gear. Contego Sports offers its products online, aiming to enhance player safety in contact sports.

ProVerum Medical is a medtech company focused on developing innovative minimally invasive devices for the treatment of benign prostatic hyperplasia (BPH). Its technology offers a safer and more effective approach to BPH treatment, allowing patients to receive care in a doctor's office or operating room with reduced invasiveness compared to traditional methods. The device addresses the enlargement of the prostate gland, which can lead to urinary difficulties, by being placed inside the urethra to restore normal urinary function. This advancement enables healthcare providers to offer improved treatment options for patients suffering from this condition.

Qualio, Inc. specializes in cloud-based quality management software tailored for the life sciences sector, including medical device manufacturers, pharmaceutical and biotech companies, and contract service providers. Founded in 2012 and headquartered in San Francisco, with an office in Dublin, Qualio's platform facilitates compliance with GxP, FDA, and ISO standards, helping organizations streamline premarket activities, registration, and regulatory requirements. The software offers comprehensive features for document control, training, risk management, complaint handling, and internal audits, among others. By uniting teams and processes within a single platform, Qualio enables over 500 companies across 80 countries to enhance efficiency, reduce risks, and foster a culture of quality, ultimately supporting faster market entry and business growth.

Magnetar Medical Devices uses low-resistance electrode to develop advanced patch technologies for a needle-free delivery of drug.

Thalman Health is focused on transforming thermometry through innovative core sensor technology that enables continuous clinical-grade monitoring of vital signs, particularly body temperature. The company develops wireless, wearable devices that integrate with a sensor-enabled platform to provide 24-hour monitoring of patients. These devices allow healthcare providers to track core body temperature in real time and receive alerts if a patient's condition begins to decline, facilitating early detection of fever and other health issues. By enhancing the ability to monitor vital signs continuously, Thalman Health aims to improve patient care and outcomes in clinical settings.

PMD Solutions is focused on transforming respiratory monitoring through the development of an innovative, body-worn wireless sensor. This device continuously and discreetly tracks patients' respiratory rates from the time of administration until discharge. By directly measuring the mechanical movements of the chest and abdomen during breathing, the technology allows healthcare professionals to accurately assess and identify any deterioration in patients' conditions. This approach aims to enhance respiratory outcomes and improve overall patient care.

Adama Innovations Ltd. is a company based in Dublin, Ireland, that specializes in developing nanotechnology solutions for advanced manufacturing. Founded in 2010 as a spin-out from CRANN, the nanotechnology institute at Trinity College Dublin, the company focuses on creating high-resolution patterns on ultra-hard materials. Its flagship product is a diamond-based nano-scale probe designed for atomic force microscopy (AFM), which allows for precise imaging, measurement, and manipulation at the nanoscale. These probes have diverse applications, including general topography, electrical analysis, and sidewall characterization. Additionally, Adama Innovations produces diamond sharp cones and flare-shaped probes for various metrology applications. The company’s technology also supports the manufacturing of medical devices by enhancing the capabilities of injection molds and forming dies, while contributing to labeling and anti-counterfeiting solutions.

Embo Medical, based at the National University of Ireland, specializes in the development of innovative medical devices for vascular embolization. Its flagship product, known as the Caterpillar, is designed to improve the efficiency of embolization procedures by allowing for superior and shorter procedural times. This device is intended for use in the peripheral vascular embolization market, which sees approximately 180,000 procedures conducted annually worldwide. Embo Medical aims to enhance the safety and cost-effectiveness of these important medical interventions, positioning itself as a key player in the field.

Apica Cardiovascular is a pre-revenue medical device company focused on a novel technology for accessing and closing the heart's apex and the peripheral vascular system. This technology facilitates the delivery of large therapeutic devices, such as transcatheter heart valves and devices used in aortic aneurysm repair and left ventricular assist device implantation, through minimally invasive surgical or percutaneous approaches. By standardizing access and closure techniques, the technology aims to minimize blood loss during procedures on a beating heart. Having successfully demonstrated its initial concept in animal and cadaver models, Apica Cardiovascular is now preparing to advance to initial clinical trials.

PMD Solutions is focused on transforming respiratory monitoring through the development of an innovative, body-worn wireless sensor. This device continuously and discreetly tracks patients' respiratory rates from the time of administration until discharge. By directly measuring the mechanical movements of the chest and abdomen during breathing, the technology allows healthcare professionals to accurately assess and identify any deterioration in patients' conditions. This approach aims to enhance respiratory outcomes and improve overall patient care.

SurgaColl Technologies Ltd., established in 2010 and headquartered in Cork, Ireland, is a medical devices company specializing in the development, production, and marketing of innovative tissue regeneration products. These products, based on technology originating from the Royal College of Surgeons in Ireland, support the body's natural healing processes. SurgaColl's portfolio includes HydroxyColl, a bone graft substitute, and ChondroColl, a biomimetic scaffold for osteochondral defect repair. The company's mission is to lead the field of regenerative medical devices, promoting faster tissue regeneration and enabling patients to return to a healthy, active lifestyle.

Biosensia Ltd. is a company based in Dublin, Ireland, that specializes in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic platform designed to provide both quantitative and qualitative laboratory test results. RapiPlex consists of a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. This advancement supports near-patient care without sacrificing analytical performance. The platform is versatile, capable of analyzing various biological samples such as whole blood, plasma, serum, urine, saliva, and milk. Biosensia also focuses on applications in theranostics, veterinary testing, and food safety. The company was founded in 2000 and was previously known as NanoComms Ltd. Biosensia operates as a subsidiary of Kypha Inc. since 2018.

neoSurgical Limited is a medical device company based in Campus, Ireland, specializing in innovative solutions for laparoscopic abdominal surgery. Founded in 2007, the company has developed neoClose, a device designed to facilitate the closure of laparoscopic wounds and reduce the risk of complications such as herniation. By enhancing the safety and efficiency of laparoscopic port site closure, neoSurgical aims to improve surgical outcomes for both patients and surgeons in the field of minimally invasive surgery.

Neuromod Devices, established in 2010 and headquartered in Dublin, Ireland, is a medical device company dedicated to the research and development of neuromodulation treatments for chronic tinnitus. The company's flagship product, the Mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the human nervous system, aiming to significantly reduce the suffering of patients affected by this condition, which impacts approximately 10% of the global adult population. Neuromod's patented technology is also being evaluated for other neurological disorders, with a commitment to empowering patients and integrating treatments seamlessly into modern lifestyles.

Radisens Diagnostics is focused on developing a digital diagnostic device designed for point-of-care testing in general practice clinics, emergency rooms, and outpatient departments. Recognizing the limitations of current tests, which often assess individual analytes and lack integration with health records, the company aims to provide a comprehensive solution that addresses the growing need for efficient diagnostics amidst rising chronic diseases such as diabetes, heart disease, and hypertension. Their platform offers multiplexed test panels that integrate immunochemistry, clinical chemistry, and hematology assays, requiring only a drop of blood to deliver instant results. Initially targeting chronic disease panels related to diabetes, heart disease, hypertension, and chronic kidney disease, Radisens Diagnostics plans to expand its offerings to include cell counting and oncology tests. This innovative approach seeks to enhance diagnostic capabilities in healthcare settings, ultimately reducing costs and improving patient outcomes by facilitating timely and informed medical decisions.

Novate Medical Technologies is a medical device development company based in New Orleans that focuses on creating affordable and sustainable medical products to meet critical global health needs. The company's flagship product, InfaClip, is a patented disposable obstetric device designed to simultaneously cut, clamp, and shield the infant, mother, and birthing attendant from infection. This innovation aims to reduce maternal and neonatal mortality rates, particularly in developing countries, by providing healthcare professionals with a tool that captures clots and prevents them from reaching the lungs. Through its efforts, Novate Medical addresses significant healthcare challenges while promoting safety and efficiency in obstetric care.

Biosensia Ltd. is a company based in Dublin, Ireland, that specializes in point-of-care in-vitro diagnostics. It has developed RapiPlex, an innovative diagnostic platform designed to provide both quantitative and qualitative laboratory test results. RapiPlex consists of a disposable assay cartridge and a compact tabletop instrument, allowing for the transition of complex immunoassays from centralized laboratories to doctors' offices or patients' bedsides. This advancement supports near-patient care without sacrificing analytical performance. The platform is versatile, capable of analyzing various biological samples such as whole blood, plasma, serum, urine, saliva, and milk. Biosensia also focuses on applications in theranostics, veterinary testing, and food safety. The company was founded in 2000 and was previously known as NanoComms Ltd. Biosensia operates as a subsidiary of Kypha Inc. since 2018.

Novate Medical Technologies is a medical device development company based in New Orleans that focuses on creating affordable and sustainable medical products to meet critical global health needs. The company's flagship product, InfaClip, is a patented disposable obstetric device designed to simultaneously cut, clamp, and shield the infant, mother, and birthing attendant from infection. This innovation aims to reduce maternal and neonatal mortality rates, particularly in developing countries, by providing healthcare professionals with a tool that captures clots and prevents them from reaching the lungs. Through its efforts, Novate Medical addresses significant healthcare challenges while promoting safety and efficiency in obstetric care.

Eblana Photonics Ltd. designs and manufactures laser diode products for various industries, including space, medical, sensor, and fiber-optic communications. Established in 2000 and based in Dun Laoghaire, Ireland, Eblana also has offices in several countries, including France, Germany, the United States, Japan, China, and Taiwan. The company emerged from advanced research collaborations with leading Irish universities, such as Trinity College Dublin and the National Microelectronics Research Centre. Founded by Dr. James O’Gorman and Prof. John Hegarty, who have extensive backgrounds in laser research, Eblana aims to commercialize scalable laser manufacturing technology. This technology enables the production of high-performance, single-wavelength lasers at reduced costs, serving diverse mass market applications in broadband, access, and enterprise markets, as well as optical sensing and metrology. Additionally, Eblana offers research and development services on a contract basis.